Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 May;26(5):209-10.
doi: 10.1002/clc.4960260502.

Aldosterone antagonism and hypertension

C Richard Conti

Aldosterone antagonism and hypertension

C Richard Conti. Clin Cardiol. 2003 May.

Erratum in

  • Clin Cardiol. 2003 Jul;26(7):A26
No abstract available

PubMed Disclaimer

References

    1. Weber MA: Clinical implications of aldosterone blockade. Am Heart J 2002; 144 (95)(suppl): 512–518 - PubMed
    1. Stier CT, Chander PN, Rocha R: Aldosterone as a mediator in cardiovascular injury. Cardiol Rev 2002; 10 (1) 97–107 - PubMed
    1. Conti, CR : Is “optimal” blood pressure an attainable goal? Clin Cardiol 2002; 25: 403–404 - PMC - PubMed
    1. White WB, Lewin AJ, Nestel P, Weiss R, Mansoor GA, Roniker B, Kleiman J, Krause S, for the Eplerenone 022 Investigators : Comparison of selective aldosterone blockade versus calcium antagonism on blood pressure, vascular compliance, and micro albuminuria in systolic hypertension in older people (abstr). Am J Hyperten 2002; 15 (4)(suppl 1): A23
    1. Krum H, Nolly H, Workman D, He W, Roniker B, Krause S, Fakouhi K: Efficacy of eplerenone added to reninangiotensin blockade in hypertensive patients. Hypertension 2002; 40 (2): 117–123 - PubMed

MeSH terms